Toxicology Drug Screening Market to Grow with a CAGR of 8.50% through 2029

The increased the extensive use of toxicological screening methods in drug development is expected to drive the Global Toxicology Drug Screening Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “Toxicology Drug Screening Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Toxicology Drug Screening Market stood at USD 11.20 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.50% through 2029. Chronic diseases play a significant role in driving the demand for drug discovery and increasing research and development (R&D) expenditure. Globally, cancer and heart diseases represent major contributors to healthcare burden. Moreover, recent advancements in technology by market players and researchers are further bolstering market growth. For example, in April 2022, CN Bio, a leading organ-on-a-chip (OOC) company, introduced the PhysioMimix "in-a-box" reagent kit for non-alcoholic steatohepatitis (NASH), a condition lacking approved therapeutics to date. The NASH-in-a-box (NIAB) kit, used in conjunction with CN Bio's PhysioMimix micro-physiological systems (MPS), equips researchers with in-house capabilities to gain physiologically relevant insights into disease mechanisms, human drug efficacy, and safety toxicology. Such advancements are expected to drive growth in the studied market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Toxicology Drug Screening Market”

Hence, the upward trajectory of R&D endeavors and the escalating demand for toxicology drug screening within the pharmaceutical and biotechnology sectors are anticipated to bolster market expansion throughout the analytical period. Nevertheless, the prolonged duration required for sample testing and the strict governmental regulations pertaining to toxicological testing of human drug compounds are forecasted to impede market growth in the forthcoming period.

The Global Toxicology Drug Screening Market is segmented into Testing Type, Product, Application, regional distribution, and company.

Based on Testing Type, the In Silico segment has emerged as the predominant market leader, the segment will continue to grow at a significant rate during the forecast period. The in-silico segment holds a significant market share in the toxicology drug screening market and is anticipated to show robust growth over the forecast period. In silico methods help identify drug targets via bioinformatics tools. They are also used to analyze the target structures to generate candidate molecules, find possible binding/active sites, check their drug-likeness, and further optimize the molecules to improve their binding characteristics. The in-silico platform is considered a potential tool in various COVID-19-related research in predicting the immune responses of potential candidate vaccines. The Universal Immune System Simulator (UISS) in silico platform has a strong potential to predict the outcome of a vaccination strategy against the COVID-19 virus. It has been frequently employed in various research to speed up and drive the discovery pipeline of the vaccine. Hence, the segment is expected to show growth.

In the Global Toxicology Drug Screening Market, the Immunotoxicity segment stands out as the primary driver of growth, particularly within the Application segment. The expansion of this market is largely propelled by the crucial role played by Immunotoxicity applications. Immunotoxicity assessment has become increasingly significant in drug development due to its focus on evaluating the impact of pharmaceutical compounds on the immune system. As drug formulations become more complex, there is a growing recognition of the importance of thoroughly understanding potential immunotoxin effects. Immunotoxicity screening is indispensable for early detection of adverse immune reactions in the drug development process, thereby mitigating the risk of unforeseen immunological issues during clinical trials or post-market release. With regulatory agencies placing greater emphasis on immune-safety profiles, pharmaceutical and biotechnology firms are increasingly integrating comprehensive immunotoxicity testing into their operational workflows.

Major companies operating in Global Toxicology Drug Screening Market are:

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Factors such as increasing research and development (R&D) initiatives within the region aimed at early detection of toxicity levels in the human body, coupled with rising demand for toxicology drug screening in the pharmaceutical and biotechnology sectors, are propelling market growth in the country. The presence of a well-established pharmaceutical industry, substantial R&D investments, robust presence of major service providers, and a growing trend of outsourcing analytical testing by pharmaceutical and biopharmaceutical firms are key drivers contributing to overall market expansion. This underscores significant involvement of major players, manufacturers, and government organizations in product development endeavors. The surge in expenditure is primarily motivated by the pursuit of competitive advantages and the substantial returns associated with newly developed products.. In addition, due to the presence of established market players and the focused R&D of new drugs, the market for clinical trials in the United States has been growing, which is also impacting the toxicology drug screening market positively.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Toxicology Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Testing Type (In Vitro, In Vivo, In Silico), By Product (Instruments, Reagents and Consumables, Animal Models, Software, Other Products), By Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, Other), By Region, By Competition, 2019-2029F”, has evaluated the future growth potential of Global Toxicology Drug Screening Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Toxicology Drug Screening Market.

Contact

TechSci Research LLC

420 Lexington Avenue,

Suite 300, New York,

United States- 10170

M: +13322586602

Email: [email protected]

Website: https://www.techsciresearch.com